Region: Global
Category: Biotechnology

Global Biotechnology

(8,348 reports matching your criteria)
  • Biochips

    ... 12.8% over the analysis period 2024-2030. DNA Chip, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth ... Read More

  • Gas Chromatography Systems

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Gas Chromatography Accessories & Consumables, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.8 Billion by ... Read More

  • Forensic Technologies and Services

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More

  • Gel Documentation Systems

    ... at a CAGR of 4.1% over the analysis period 2024-2030. Gel Documentation Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end ... Read More

  • Laboratory Informatics

    ... CAGR of 8.4% over the analysis period 2024-2030. Laboratory Information Management Systems (LIMS), one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$3.5 Billion by the end ... Read More

  • mRNA Platform

    ... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More

  • Drug Discovery Technologies

    ... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More

  • Amino Acids

    ... CAGR of 6.0% over the analysis period 2024-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$13.6 Billion by the end of the analysis ... Read More

  • Animal Feed Additives

    ... at a CAGR of 5.4% over the analysis period 2024-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$20.7 Billion by the end of ... Read More

  • Microplate Systems

    ... CAGR of 4.6% over the analysis period 2024-2030. Microplate Readers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$851.2 Million by the end of the analysis ... Read More

  • Biobanks

    ... 7.7% over the analysis period 2024-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis ... Read More

  • Biofuel Enzymes

    ... CAGR of 8.3% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$683.8 Million by the end of the analysis period. ... Read More

  • Antimicrobial Susceptibility Testing

    ... at a CAGR of 3.4% over the analysis period 2024-2030. Manual Products, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.5 Billion by the end of ... Read More

  • qPCR and dPCR Instrumentation

    ... 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. qPCR Instrumentation, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$11.3 Billion by the ... Read More

  • DNA Sequencing

    ... CAGR of 11.8% over the analysis period 2024-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the ... Read More

  • In Situ Hybridization (ISH)

    ... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More

  • RNA Analysis / Transcriptomics

    ... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and ... Read More

  • Proteomics

    ... 10.1% over the analysis period 2024-2030. Proteomics Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth ... Read More

  • Nanotechnology

    ... 11.3% over the analysis period 2024-2030. Nanocomposites, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$80.8 Billion by the end of the analysis period. Growth in ... Read More

  • Nanopatterning

    ... 17.7% over the analysis period 2024-2030. UV Nanoimprint Lithography Technology, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More

  • Cancer Therapies

    ... CAGR of 10.4% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$112.8 Billion by the end of the analysis period. ... Read More

  • Marine Biotechnology

    ... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More

  • Cell Free Protein Expression

    ... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Protein-Protein Interaction Application, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$193.3 Million by ... Read More

  • Coatings for Medical Devices

    ... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial Coatings, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the ... Read More

  • Biosensors

    ... 7.2% over the analysis period 2024-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Cookie Settings